These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34586144)

  • 1. A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration.
    Yuan X; Jia Z; Li J; Liu Y; Huang Y; Gong Y; Guo X; Chen X; Cen J; Liu J
    J Mater Chem B; 2021 Sep; 9(37):7835-7847. PubMed ID: 34586144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease.
    Zhou H; Gong Y; Liu Y; Huang A; Zhu X; Liu J; Yuan G; Zhang L; Wei JA; Liu J
    Biomaterials; 2020 Apr; 237():119822. PubMed ID: 32035322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Nanocarrier for Synergistic Treatment of Alzheimer's Disease by Inhibiting β-Amyloid Aggregation and Scavenging Reactive Oxygen Species.
    Wang C; Song X; Li P; Sun S; Su J; Liu S; Wei W
    ACS Appl Mater Interfaces; 2024 May; 16(21):27127-27138. PubMed ID: 38747495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.
    Kuo YC; Chen CL; Rajesh R
    Acta Biomater; 2019 Mar; 87():207-222. PubMed ID: 30716553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.
    Yin T; Xie W; Sun J; Yang L; Liu J
    ACS Appl Mater Interfaces; 2016 Aug; 8(30):19291-302. PubMed ID: 27411476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-Infrared Photothermally Enhanced Photo-Oxygenation for Inhibition of Amyloid-β Aggregation Based on RVG-Conjugated Porphyrinic Metal-Organic Framework and Indocyanine Green Nanoplatform.
    Wang J; Gu Y; Liu X; Fan Y; Zhang Y; Yi C; Cheng C; Yang M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm-camouflaged Prussian blue synergistic mitochondrial mass enhancement for Alzheimer's disease based on Cu
    Li L; Xiong Y; Zhang Y; Yan Y; Zhao R; Yang F; Xie M
    J Control Release; 2024 Nov; 375():269-284. PubMed ID: 39245418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-Functionalized Prussian Blue Nanomaterial for Antioxidant Stress and NIR Photothermal Therapy against Alzheimer's Disease.
    Song X; Ding Q; Wei W; Zhang J; Sun R; Yin L; Liu S; Pu Y
    Small; 2023 Oct; 19(41):e2206959. PubMed ID: 37322406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-Induced Chiral Iron Copper Selenide Nanoparticles Prevent β-Amyloidopathy In Vivo.
    Zhang H; Hao C; Qu A; Sun M; Xu L; Xu C; Kuang H
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7131-7138. PubMed ID: 32067302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared Responsive Dopamine/Melatonin-Derived Nanocomposites Abrogating in Situ Amyloid β Nucleation, Propagation, and Ameliorate Neuronal Functions.
    Srivastava AK; Roy Choudhury S; Karmakar S
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5658-5670. PubMed ID: 31986005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-Activated Near-Infrared-Responsive Polyoxometalates Used for Photothermal Treatment of Alzheimer's Disease.
    Ma M; Gao N; Sun Y; Du X; Ren J; Qu X
    Adv Healthc Mater; 2018 Oct; 7(20):e1800320. PubMed ID: 29920995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use new poly (ε-caprolactone/collagen/NBG) nerve conduits along with NGF for promoting peripheral (sciatic) nerve regeneration in a rat.
    Mohamadi F; Ebrahimi-Barough S; Nourani MR; Ahmadi A; Ai J
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):34-45. PubMed ID: 29557195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
    Peng YB; Tao C; Tan CP; Zhao P
    J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of Nerve Growth Factor Loaded in Porous Silicon Nanostructures in an Alzheimer's Disease Model and Potential Delivery to the Brain.
    Zilony-Hanin N; Rosenberg M; Richman M; Yehuda R; Schori H; Motiei M; Rahimipour S; Groisman A; Segal E; Shefi O
    Small; 2019 Nov; 15(45):e1904203. PubMed ID: 31482695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CeO
    Chi M; Liu J; Li L; Zhang Y; Xie M
    ACS Appl Mater Interfaces; 2024 Jul; 16(28):35898-35911. PubMed ID: 38954799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared target enhanced peripheral clearance of amyloid-β in Alzheimer's disease model.
    Ma M; Liu Z; Gao N; Dong K; Pi Z; Kang L; Du X; Ren J; Qu X
    Biomaterials; 2021 Sep; 276():121065. PubMed ID: 34391018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
    Rodrigues BDS; Kanekiyo T; Singh J
    Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements.
    Shastri D; Raj V; Lee S
    Ageing Res Rev; 2024 Aug; 99():102379. PubMed ID: 38901740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.